{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:50:43Z","timestamp":1787727043652,"version":"build-2784847793"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1159351"],"award-info":[{"award-number":["OPP1159351"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12889-018-5498-2","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T17:18:17Z","timestamp":1525367897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Estimating the incidence of enteric fever in children in India: a multi-site, active fever surveillance of pediatric cohorts"],"prefix":"10.1186","volume":"18","author":[{"name":"NSSEFI Collaborators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"John","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Bavdekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temsunaro","family":"Rongsen-Chandola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanta","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3656-564X","authenticated-orcid":false,"given":"Gagandeep","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,3]]},"reference":[{"issue":"5","key":"5498_CR1","first-page":"346","volume":"82","author":"JA Crump","year":"2004","unstructured":"Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ. 2004;82(5):346\u201353.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"5498_CR2","doi-asserted-by":"publisher","first-page":"010401","DOI":"10.7189\/jogh.01.010401","volume":"2","author":"GC Buckle","year":"2012","unstructured":"Buckle GC, Walker CL, Black RE. Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010. J Glob Health. 2012;2(1):010401.","journal-title":"J Glob Health"},{"issue":"3","key":"5498_CR3","first-page":"304","volume":"22","author":"R Bahl","year":"2004","unstructured":"Bahl R, Sinha A, Poulos C, Whittington D, Sazawal S, Kumar R, et al. Costs of illness due to typhoid fever in an Indian urban slum community: implications for vaccination policy. J Health Popul Nutr. 2004;22(3):304\u201310.","journal-title":"J Health Popul Nutr"},{"issue":"4","key":"5498_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa0807521","volume":"361","author":"D Sur","year":"2009","unstructured":"Sur D, Ochiai RL, Bhattacharya SK, Ganguly NK, Ali M, Manna B, et al. A cluster-randomized effectiveness trial of vi typhoid vaccine in India. N Engl J Med. 2009;361(4):335\u201344.","journal-title":"N Engl J Med"},{"issue":"4","key":"5498_CR5","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2471\/BLT.06.039818","volume":"86","author":"RL Ochiai","year":"2008","unstructured":"Ochiai RL, Acosta CJ, Danovaro-Holliday MC, Baiqing D, Bhattacharya SK, Agtini MD, et al. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ. 2008;86(4):260\u20138.","journal-title":"Bull World Health Organ"},{"key":"5498_CR6","unstructured":"Typhoid vaccines: WHO position paper. Wkly Epidemiol Rec. 2008;83(6):49-59. PubMed PMID: 18260212."},{"issue":"7","key":"5498_CR7","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1128\/AAC.44.7.1855-1859.2000","volume":"44","author":"NT Chinh","year":"2000","unstructured":"Chinh NT, Parry CM, Ly NT, Ha HD, Thong MX, Diep TS, et al. A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrob Agents Chemother. 2000;44(7):1855\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"22","key":"5498_CR8","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1056\/NEJMra020201","volume":"347","author":"CM Parry","year":"2002","unstructured":"Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. Typhoid fever. N Engl J Med. 2002;347(22):1770\u201382.","journal-title":"N Engl J Med"},{"issue":"3","key":"5498_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1128\/AAC.00447-06","volume":"51","author":"CM Parry","year":"2007","unstructured":"Parry CM, Ho VA, Phuong l T, Bay PV, Lanh MN, Tung l T, et al. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother. 2007;51(3):819\u201325.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9180","key":"5498_CR10","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S0140-6736(98)09001-1","volume":"354","author":"A Sinha","year":"1999","unstructured":"Sinha A, Sazawal S, Kumar R, Sood S, Reddaiah VP, Singh B, et al. Typhoid fever in children aged less than 5 years. Lancet. 1999;354(9180):734\u20137.","journal-title":"Lancet"},{"issue":"3","key":"5498_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/cid\/civ295","volume":"61","author":"VK Mohan","year":"2015","unstructured":"Mohan VK, Varanasi V, Singh A, Pasetti MF, Levine MM, Venkatesan R, et al. Safety and immunogenicity of a vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study. Clin Infect Dis. 2015;61(3):393\u2013402.","journal-title":"Clin Infect Dis"},{"issue":"10111","key":"5498_CR12","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","volume":"390","author":"C Jin","year":"2017","unstructured":"Jin C, Gibani MM, Moore M, Juel HB, Jones E, Meiring J, et al. Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial. Lancet. 2017;390(10111):2472\u201380.","journal-title":"Lancet"},{"issue":"4","key":"5498_CR13","doi-asserted-by":"publisher","first-page":"e0004616","DOI":"10.1371\/journal.pntd.0004616","volume":"10","author":"J John","year":"2016","unstructured":"John J, Van Aart CJ, Grassly NC. The burden of typhoid and paratyphoid in India: systematic review and meta-analysis. PLoS Negl Trop Dis. 2016;10(4):e0004616.","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"5498_CR14","doi-asserted-by":"publisher","first-page":"e570","DOI":"10.1016\/S2214-109X(14)70301-8","volume":"2","author":"V Mogasale","year":"2014","unstructured":"Mogasale V, Maskery B, Ochiai RL, Lee JS, Mogasale VV, Ramani E, et al. Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment. Lancet Glob Health. 2014;2(10):e570\u201380.","journal-title":"Lancet Glob Health"},{"key":"5498_CR15","doi-asserted-by":"publisher","first-page":"e01229","DOI":"10.7554\/eLife.01229","volume":"2","author":"S Baker","year":"2013","unstructured":"Baker S, Duy PT, Nga TV, Dung TT, Phat VV, Chau TT, et al. Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure. elife. 2013;2:e01229.","journal-title":"elife"},{"issue":"10","key":"5498_CR16","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/tmi.12762","volume":"21","author":"S Divyashree","year":"2016","unstructured":"Divyashree S, Nabarro LE, Veeraraghavan B, Rupali P. Enteric fever in India: current scenario and future directions. Tropical Med Int Health. 2016;21(10):1255\u201362.","journal-title":"Tropical Med Int Health"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-018-5498-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-018-5498-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-018-5498-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T12:34:51Z","timestamp":1589459691000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-018-5498-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,3]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["5498"],"URL":"https:\/\/doi.org\/10.1186\/s12889-018-5498-2","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,3]]},"assertion":[{"value":"8 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol has been approved by the Christian Medical College Institutional Review Board (10,393 dated 30.11.2016). IRB approvals from the participating sites have been obtained. KEM Hospital Research Center Ethics Committee (07\/10\/2017) Jamia Hamdard Institutional Ethics Committee on 13\/09\/2017 and Institutional Ethics Committee of National Institute for Cholera and Enteric Diseases Kolkata (09\/08\/2017).Written informed consent will be obtained from parents of participating children. Written assent will be obtained from age-eligible children.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"594"}}